Concepedia

Mike Frohn

MF

Statistics

Publications

10

Citations

516

H-Index

10

Active since

1980

Affiliations

Amgen (United States)(Current)

Epix Pharmaceuticals (United States)

Mike Frohn is an author at Amgen (United States) specializing in medicine, pharmacology, and molecular pharmacology.

Top concepts

Publications per year

1980–2014

10

Publications

10

A Soluble Base for the Copper-Catalyzed Imidazole N-Arylations with Aryl Halides

Longbin Liu, Mike Frohn, Ning Xi et al. · The Journal of Organic Chemistry · 2005 · 172 citations

Potent hFPRL1 (ALXR) agonists as potential anti-inflammatory agents

Roland W. Bürli, Han Xu, Xiaoming Zou et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 125 citations · Full text

, , +6

Discovery of AMG 369, a Thiazolo[5,4-<i>b</i>]pyridine Agonist of S1P<sub>1</sub> and S1P<sub>5</sub>

Victor J. Cee, Mike Frohn, Brian A. Lanman et al. · ACS Medicinal Chemistry Letters · 2010 · 54 citations · Full text

, , +17

N-substituted azaindoles as potent inhibitors of Cdc7 kinase

Marian C. Bryan, James R. Falsey, Mike Frohn et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 37 citations · Full text

, , +4

New ‘chemical probes’ to examine the role of the hFPRL1 (or ALXR) receptor in inflammation

Mike Frohn, Han Xu, Xiaoming Zou et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 31 citations · Full text

, , +10

1–5 of 10